Poland
# |
Name |
Cash and Short-Term Investments |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 59.26 M
|
Dec. 31, 2023 | USD 6.78 | -1.52% |
|
Poland |
|
2 |
USD 19.20 M
|
Dec. 31, 2023 | USD 12.77 | 1.67% |
|
Poland |
|
3 |
USD 16.72 M
|
Dec. 31, 2023 | USD 9.53 | -0.94% |
|
Poland |
|
4 |
USD 13.43 M
|
Dec. 31, 2023 | USD 10.78 | -0.36% |
|
Poland |
|
5 |
USD 2.62 M
|
Dec. 31, 2023 | USD 1.88 | 0.22% |
|
Poland |
The Clinical Trials company in Poland with the highest Cash and Short-Term Investments is Ryvu Therapeutics S.A. (Warsaw Stock Exchange: RVU.WA) at USD 59.26 M.
The Clinical Trials company in Poland with the lowest Cash and Short-Term Investments is Medinice S.A. (Warsaw Stock Exchange: ICE.WA) at USD 2.62 M.
The top 10 Clinical Trials companies in Poland by Cash and Short-Term Investments are Ryvu Therapeutics S.A., Captor Therapeutics Spolka Akcyjna, Poltreg S.A., Selvita S.A. and Medinice S.A..
The bottom 10 Clinical Trials companies in Poland by Cash and Short-Term Investments are Medinice S.A., Selvita S.A., Poltreg S.A., Captor Therapeutics Spolka Akcyjna and Ryvu Therapeutics S.A..